← Back to Patent Explorer
US4330338A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical coating composition, and preparation and dosages so coated

Assignee: Purdue Research Foundation
•
Filing: 1980-05-23
•
Granted: 1982-05-18
•
Expires: 2000-05-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical coatings in the form of aqueous dispersion of a water insoluble polymer prepared by dissolving the polymer in a water immiscible organic solvent, emulsifying the organic solution in water, optionally with the aid of additives, and stripping the organic solvent from the system to provide a colloidal, or near colloidal, aqueous dispersion or latex of small, even sized polymeric particles which are applied to pharmaceutical dosages from highly loaded latices. The latexes, which display resistance to bacterial and mold growth and, when combined with selected additives, provides convenient, attractive coating compositions which afford excellent protection and varied release properties to pharmaceutical dosages.

Inventors

  • 👤 Gilbert S. Banker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:34
CPC Classifications
A; A23; A23G; A23G3/00; A23G3/34; A23G3/343; A23P; A23P20/00; A23P20/10; A23P20/105; A23G2200/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 108 words
A coating composition for pharmaceutical dosages comprising: a bacteria growth resistant aqueous dispersion of submicron average sized spherical particles formed of at least one water insoluble polymer selected the group consisting of ethyl cellulose, polyvinyl acetate phthalate, cellulose acetate phthalate, and hydroxy propyl methyl cellulose phthalate; at least one annealing agent in the form of a water soluble polymer; at least one plasticizer selected from the group consisting of propylene glycol, glycerin, glyceryl triacetate and polyethylene glycol; an emulsifying agent; and an emulsion stabilizer selected from the group consisting of cetyl alcohol and n-decane; the solids contents of the aqueous dispersion being at least 40 percent by weight.
Claim 2
Dependent Claim 108 words
A coating composition for pharmaceutical dosages comprising: a bacteria growth resistant aqueous dispersion of submicron average sized spherical particles formed of at least one water insoluble polymer selected the group consisting of ethyl cellulose, polyvinyl acetate phthalate, cellulose acetate phthalate, and hydroxy propyl methyl cellulose phthalate; at least one annealing agent in the form of a water soluble polymer; at least one plasticizer selected from the group consisting of propylene glycol, glycerin, glyceryl triacetate and polyethylene glycol; an emulsifying agent; and an emulsion stabilizer selected from the group consisting of cetyl alcohol and n-decane; the solids contents of the aqueous dispersion being at least 40 percent by weight.
Claim 3
Dependent Claim 39 words
A coating composition as set forth in claim 1 in which the water soluble polymer constituting the annealing agent is selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose, methyl cellulose, methyl ethyl cellulose, polyvinylpyrrolidone and sodium carboxymethylcellulose.
Claim 4
Dependent Claim 52 words
A coating composition for pharmaceutical dosages as set forth in claim 1 in which the annealing agent is selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose, methyl cellulose, methyl ethyl cellulose, polyvinylpyrrolidone, sodium carboxmethylcellulose, gums, carboxyvinyl polymer, hydroxyethyl cellulose, solium alginate, propylene glycol ester of alginic acid and polyvinyl alcohol.
Claim 5
Dependent Claim 21 words
A coating composition for pharmaceutical dosages as set forth in claim 1 in which the emulsifying agent comprises sodium lauryl sulfate.
Claim 6
Dependent Claim 103 words
A coating composition for pharmaceutical dosages as set forth in claim 1 in which at least one additive selected from the group consisting of quaternary ammonium halides, fatty alcohol ethoxylates, polyoxyethylene condensation products, polyglycerol esters of fatty acids, polyoxethylene sorbitan monolaurate, polyoxethylene sorbitan tristerarate, polyoxethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, propylene glycol mono and diesters of fats and fatty acids, sorbitan monstearate, beeswax, candelilla wax, carnauba wax, cocoa butter, fatty acids, monoglycerides, diglycerides, triglycerides, glycerol-lacto steaarate, glycerol-lacto oleate, glycerol-lacto palmitate, glyceryl-lacto esters of fatty acids, lauric acid, lauryl alcohol, linoleic acid, octyl alcohol, chlorowax, octyl acetate, and paraffin as included in the dispersion.
Claim 7
Dependent Claim 91 words
A coating composition for pharmaceutical dosages, the composition comprising: a bacteria growth resistant aqueous dispersion of submicron average sized spherical particles formed of ethyl cellulose; at least one annealing agent in the form of a water soluble polymer; at least one plasticizer selected from the group consisting of propylene glycol, glycerin, glyceryl triacetate and polyethylene glycol; sodium lauryl sulfate emulsifying agent; and an emulsion stabilizer selected from the group consisting of cetyl alcohol and n-decane; the solids contents of the aqueous dispersion being between 40 percent and 60 percent by weight.
Claim 8
Dependent Claim 91 words
A coating composition for pharmaceutical dosages, the composition comprising: a bacteria growth resistant aqueous dispersion of submicron average sized spherical particles formed of ethyl cellulose; at least one annealing agent in the form of a water soluble polymer; at least one plasticizer selected from the group consisting of propylene glycol, glycerin, glyceryl triacetate and polyethylene glycol; sodium lauryl sulfate emulsifying agent; and an emulsion stabilizer selected from the group consisting of cetyl alcohol and n-decane; the solids contents of the aqueous dispersion being between 40 percent and 60 percent by weight.

References Cited (Backward Citations)

US3522070A Cited
US3449489A Cited
US3935326A Cited
US3539380A Cited
US3640741A Cited
US4177177A Cited
US4252786A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-17 1985-11-16 1986-05-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-17 1989-11-16 1990-05-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-17 1993-11-16 1994-05-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag